Skip to main content

Month: July 2020

Vir Biotechnology Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN FRANCISCO, July 10, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today announced the closing of its previously announced underwritten public offering of 8,214,285 shares of its common stock at a public offering price of $42.00 per share. This includes the exercise in full by the underwriters of their option to purchase up to 1,071,428 additional shares of common stock. The aggregate gross proceeds to Vir from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses, were approximately $345.0 million.Goldman Sachs & Co. LLC, BofA Securities, Cowen and Barclays acted as joint book-running managers for the offering. Needham & Company acted as lead-manager...

Continue reading

Board of Directors of Westell Technologies, Inc. Approves Plan to Terminate Registration of Class A Common Stock

AURORA, Ill., July 10, 2020 (GLOBE NEWSWIRE) — Westell Technologies, Inc. (NASDAQ:WSTL) today announced that a Special Committee of independent directors has recommended, and its Board of Directors has approved, a plan for a proposed transaction whereby the Company would effect a reverse/forward stock split of the Company’s shares of Class A Common Stock and Class B Common Stock, in conjunction with terminating the Company’s public company reporting obligations and delisting the Company’s Class A Common Stock from the NASDAQ Capital Market. It is expected that this transaction would be effectuated late in the third quarter or early in the fourth quarter of calendar year 2020, subject to stockholders approving the proposed transaction at the Annual Meeting of Stockholders.The Company is taking these steps to avoid the substantial...

Continue reading

Dynavax and Times Pharmacy Announce Partnership to Offer HEPLISAV-B® Hepatitis B Vaccine to Customers Throughout Oahu, with a Focus on People with Diabetes

–   People with diabetes are two times more likely to become infected with the hepatitis B virus (HBV) and up to four times as likely to get HBV-related liver cancer–   Hawaii has one of the highest rates of liver cancer in the U.S. and hepatitis B is a leading causeEMERYVIILLE, Calif., July 10, 2020 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation, a biopharmaceutical company focused on developing and commercializing novel vaccines, and Times Pharmacy, have partnered with Hep Free Hawaii to provide HEPLISAV-B [Hepatitis B Vaccine (Recombinant), Adjuvanted] at pharmacy locations on Oahu, with a focus on people living with diabetes. Through this partnership, pharmacy customers will have access to HEPLISAV-B, the only FDA-approved two-dose hepatitis B vaccine for adults that is completed in one month. HEPLISAV-B is...

Continue reading

NAV CANADA announces third quarter financial results

OTTAWA, July 10, 2020 (GLOBE NEWSWIRE) — NAV CANADA today released its financial results for the three and nine months ended May 31, 2020.In the third quarter of fiscal 2020, the Company’s air traffic growth decreased 59.4% on a year over year basis, as measured in weighted charging units, as a result of the COVID-19 pandemic. As a result, the Company’s revenue for the third quarter of fiscal 2020 was $159 million, compared to $351 million over the same period in fiscal 2019.The COVID-19 pandemic and the resulting economic contraction has had, and is expected to continue to have, a significant negative impact on global air traffic and on the aviation industry. NAV CANADA has seen the number of air traffic movements decline since March 2020 as a result of travel restrictions imposed by governments, the closing of international borders...

Continue reading

NAV CANADA annonce ses résultats financiers pour le troisième trimestre

OTTAWA, 10 juill. 2020 (GLOBE NEWSWIRE) — NAV CANADA a annoncé aujourd’hui ses résultats financiers pour les périodes de trois et de neuf mois terminées le 31 mai 2020.Au cours du troisième trimestre de l’exercice 2019-2020, la croissance du trafic aérien de la Société, mesurée en unités de redevance pondérées, a diminué de 59,4 % par rapport à l’exercice précédent en raison de la pandémie de COVID-19. Pour cette raison, les produits de la Société pour ce troisième trimestre ont totalisé 159 millions de dollars, comparativement à 351 millions de dollars pour la même période de l’exercice 2018-2019.La pandémie de COVID-19 et la contraction de l’économie qui s’en est suivie ont nui et devraient continuer de nuire considérablement à la circulation aérienne mondiale et au secteur de l’aviation. NAV CANADA a constaté que le nombre de...

Continue reading

WEYCO Group, Inc. Second Quarter 2020 Earnings Conference Call

Milwaukee, WI, July 10, 2020 (GLOBE NEWSWIRE) — WEYCO Group, Inc. (NASDAQ: WEYS), a global marketer of footwear, plans to announce second quarter 2020 financial results after the close on Tuesday, August 4, 2020.  Additionally, Thomas W. Florsheim, Jr., Chairman and CEO, will host a conference call on Wednesday, August 5, 2020, at 11:00 a.m. Eastern Time to discuss the financial results in more detail. To participate in the call, you will first need to pre-register online. Pre-registration takes only a few minutes and you may pre-register at any time, including up to and after the call start time. To pre-register, please go to: http://www.directeventreg.com/registration/event/6982938. The pre-registration process will provide the conference call phone number and a passcode required to enter the call. A replay will be available for...

Continue reading

Verizon Recommends Stockholders Reject Mini-Tender Offer from Ponos Industries LLC

NEW YORK, July 10, 2020 (GLOBE NEWSWIRE) — Verizon Communications Inc. (“Verizon”) received notice of a “mini-tender” offer by Ponos Industries LLC (“Ponos”) and recommends that its stockholders reject the unsolicited offer. Pursuant to the offer, which is dated June 26, 2020, Ponos is offering to purchase up to 2 million shares of Verizon common stock at $60.00 per share. While this price is above the current market price of Verizon common stock, the offer is conditioned upon the closing price of Verizon’s shares exceeding the $60.00 offer price, as noted below. The offer expires on July 30, 2020, unless extended.  Verizon is not associated with Ponos or its “mini-tender” offer. According to guidance on the U.S. Securities and Exchange Commission (“SEC”) website, mini-tender offers “have been increasingly used to catch...

Continue reading

CapStar Announces Date for Second Quarter 2020 Earnings Release and Conference Call

NASHVILLE, Tenn., July 10, 2020 (GLOBE NEWSWIRE) — CapStar Financial Holdings, Inc. (“CapStar”) (NASDAQ:CSTR) announced today that it will issue its second quarter 2020 earnings release after the market closes on July 23, 2020.CapStar will also host a conference call and webcast at 9:00 a.m. Central Time on Friday, July 24, 2020 to discuss its financial results. Analysts and investors may participate in the question-and-answer session.Conference Call and Webcast Information:Date: Friday, July 24, 2020Time: 9:00 a.m. Central TimeTelephone Access: (844) 412-1002; Conference ID: 4376815Webcast Access: A live webcast will be available on CapStar’s website at www.ir.capstarbank.com. An archived version of the webcast will be available in the same location shortly after the live call has ended.About CapStar Financial Holdings, Inc. CapStar...

Continue reading

CBTX, Inc. Announces Date of Second Quarter 2020 Financial Results Conference Call

HOUSTON, July 10, 2020 (GLOBE NEWSWIRE) — CBTX, Inc., or the Company (NASDAQ: CBTX), the bank holding company for CommunityBank of Texas, N.A., or the Bank, today announced it will hold a quarterly conference call to discuss second quarter 2020 financial results on Thursday, July 30, 2020 at 8:00 a.m. Central Time (9:00 a.m. Eastern Time).To access the live webcast of the conference call, individuals can visit the Investor Relations page of the Company’s website: https://ir.cbtxinc.com/events-and-presentations. An archived edition of the earnings webcast will also be posted on the Company’s website later that day and will remain available to interested parties via the same link for one year.The conference call can also be accessed by dialing (877) 620-1733 if calling from the U.S. or Canada (or (470) 414-9785 if calling from outside...

Continue reading

LeMaitre Vascular Will Announce Second Quarter 2020 Earnings Results on July 23, 2020

BURLINGTON, Mass., July 10, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2020 financial results on Thursday, July 23, 2020, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.Access to the live call is available by dialing 844-239-5284 (+1-512-961-6497 for international callers), passcode 1390218. The call can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.About LeMaitre VascularLeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.